128 related articles for article (PubMed ID: 38431223)
41. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
[TBL] [Abstract][Full Text] [Related]
42. Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
Cohen-Mekelburg S; Schneider Y; Gold S; Ghosh G; Rosenblatt R; Hajifathalian K; Scherl E; Schnoll-Sussman F; Katz P; Steinlauf A
Dig Dis Sci; 2019 Aug; 64(8):2273-2279. PubMed ID: 30815820
[TBL] [Abstract][Full Text] [Related]
43. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines.
Mooiweer E; van der Meulen AE; van Bodegraven AA; Jansen JM; Mahmmod N; Nijsten J; van Oijen MG; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013 Nov; 19(12):2603-10. PubMed ID: 24030524
[TBL] [Abstract][Full Text] [Related]
44. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
[TBL] [Abstract][Full Text] [Related]
45. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
[No Abstract] [Full Text] [Related]
46. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
47. Development of a clinical prediction model for the onset of functional decline in people aged 65-75 years: pooled analysis of four European cohort studies.
Jonkman NH; Colpo M; Klenk J; Todd C; Hoekstra T; Del Panta V; Rapp K; van Schoor NM; Bandinelli S; Heymans MW; Mauger D; Cattelani L; Denkinger MD; Rothenbacher D; Helbostad JL; Vereijken B; Maier AB; Pijnappels M
BMC Geriatr; 2019 Jun; 19(1):179. PubMed ID: 31248370
[TBL] [Abstract][Full Text] [Related]
48. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden.
Axelrad JE; Olén O; Söderling J; Roelstraete B; Khalili H; Song M; Faye A; Eberhardson M; Halfvarson J; Ludvigsson JF
J Crohns Colitis; 2023 Oct; 17(9):1395-1409. PubMed ID: 36994851
[TBL] [Abstract][Full Text] [Related]
50. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
[TBL] [Abstract][Full Text] [Related]
51. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
[TBL] [Abstract][Full Text] [Related]
52. Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
Ten Hove JR; Bogaerts JMK; Bak MTJ; Laclé MM; Meij V; Derikx LAAP; Hoentjen F; Mahmmod N; van Tuyl SA; Oldenburg B
Inflamm Bowel Dis; 2019 Jan; 25(2):377-384. PubMed ID: 30085111
[TBL] [Abstract][Full Text] [Related]
53. High frequency of early colorectal cancer in inflammatory bowel disease.
Lutgens MW; Vleggaar FP; Schipper ME; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Oldenburg B; Samsom M
Gut; 2008 Sep; 57(9):1246-51. PubMed ID: 18337322
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score.
Aleksandrova K; Reichmann R; Kaaks R; Jenab M; Bueno-de-Mesquita HB; Dahm CC; Eriksen AK; Tjønneland A; Artaud F; Boutron-Ruault MC; Severi G; Hüsing A; Trichopoulou A; Karakatsani A; Peppa E; Panico S; Masala G; Grioni S; Sacerdote C; Tumino R; Elias SG; May AM; Borch KB; Sandanger TM; Skeie G; Sánchez MJ; Huerta JM; Sala N; Gurrea AB; Quirós JR; Amiano P; Berntsson J; Drake I; van Guelpen B; Harlid S; Key T; Weiderpass E; Aglago EK; Cross AJ; Tsilidis KK; Riboli E; Gunter MJ
BMC Med; 2021 Jan; 19(1):1. PubMed ID: 33390155
[TBL] [Abstract][Full Text] [Related]
55. Use of the Living Kidney Donor Profile Index in the Canadian Kidney Transplant Recipient Population: A Validation Study.
Shantier M; Li Y; Ashwin M; Famure O; Singh SK
Can J Kidney Health Dis; 2020; 7():2054358120906976. PubMed ID: 32128225
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
57. ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.
Hui M; Ma J; Yang H; Gao B; Wang F; Wang J; Lv J; Zhang L; Yang L; Zhao M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836039
[TBL] [Abstract][Full Text] [Related]
58. Current management of inflammatory bowel disease and colorectal cancer.
Mattar MC; Lough D; Pishvaian MJ; Charabaty A
Gastrointest Cancer Res; 2011 Mar; 4(2):53-61. PubMed ID: 21673876
[TBL] [Abstract][Full Text] [Related]
59. Dysplasia Surveillance in Inflammatory Bowel Disease: A Cohort Study.
Saraiva S; Rosa I; Moleiro J; Pereira da Silva J; Fonseca R; Dias Pereira A
GE Port J Gastroenterol; 2021 Feb; 28(2):97-105. PubMed ID: 33791396
[TBL] [Abstract][Full Text] [Related]
60. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
